Skip to main content
logo
NeuroPace, Inc. (NPCE)
NASDAQ: NPCE · Real-Time Price · USD
13.82
-0.37 (-2.61%)
At close: Mar 17, 2026, 4:00 PM EDT
13.82
0.00 (0.00%)
After-hours: Mar 17, 2026, 4:27 PM EDT

NeuroPace Revenue

In the year 2025, NeuroPace had annual revenue of $99.99M with 25.13% growth. NeuroPace had revenue of $26.59M in the quarter ending December 31, 2025, with 23.86% growth.

Revenue (ttm)
$99.99M
Revenue Growth
+25.13%
P/S Ratio
4.65
Revenue / Employee
$478,402
Employees
209
Market Cap
465.28M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202599.99M20.08M25.13%
Dec 31, 202479.91M14.49M22.14%
Dec 31, 202365.42M19.90M43.72%
Dec 31, 202245.52M337.00K0.75%
Dec 31, 202145.18M4.05M9.83%
Dec 31, 202041.14M4.17M11.27%
Dec 31, 201936.97M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Varex Imaging854.40M
Orthofix Medical822.31M
Viemed Healthcare270.28M
OrthoPediatrics236.35M
Axogen225.21M
Cytek Biosciences201.49M
SI-BONE200.93M
Pacific Biosciences of California160.01M
Revenue Rankings

NPCE News

More News